Measuring body composition in children: research and practice

Prior, Emily; Uthaya, Sabita; Gale, Chris

doi:10.1136/archdischild-2022-324920

Cited by 4 publications

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic review by Bander et al 15 assessed the association between body composition in the first 5 years of life and later cardiometabolic diseases 15. They found that low body mass index (BMI) in infancy and higher BMI in childhood seems to be associated with non-communicable disease in adulthood, however few studies measured body composition using validated methods, and instead used BMI 16…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Infant fat mass and later child and adolescent health outcomes: a systematic review

Amati,

McCann,

Castañeda-Gutiérrez

et al. 2023

Arch Dis Child

Self Cite

View full text Add to dashboard Cite

ObjectiveObesity and excess adiposity are leading causes of metabolic and cardiovascular morbidity and mortality. Early identification of individuals at risk is key for preventive strategies. We examined the relationship between infant body composition (0–2 years of age) and later (>2 years) health outcomes using a systematic review.DesignWe preregistered the study on PROSPERO (ID 288013) and searched Embase, PubMed and Cochrane databases for English language publications using the Medical Subject Headings (MeSH) terms ‘infant’ and ‘body composition’ and ‘risk’ between January 1946 and February 2022. We included studies which assessed infant body composition using predetermined in vivo methods other than body mass index (BMI).ResultsWe identified 6015 articles. After abstract screening to assess eligibility, we reviewed 130 full text publications. 30 were included in the final assessment and narrative synthesis. Meta-analysis was not possible due to heterogeneity of results. All 30 studies were of high quality and reported associations between infant body composition and 19 different health outcomes after 2 years of age. Outcome measurements ranged from 2 years to 16 years. The strongest associations were found between infant fat mass and later fat mass (7 studies), and later BMI (5 studies). For 11 of the outcomes assessed, there was no relationship to infant adiposity detected.ConclusionsCurrent evidence, from a small number of studies, suggests a positive association between infant adiposity and future adiposity or BMI, but the validity of infant body composition as a biomarker of future health remains inconclusive. Carefully designed, standardised studies are required to identify the value of infant body composition for predicting later health.Trial registrationPROSPERO: 288013

show abstract

Section: Introductionmentioning

confidence: 99%

“… 15 They found that low body mass index (BMI) in infancy and higher BMI in childhood seems to be associated with non-communicable disease in adulthood, however few studies measured body composition using validated methods, and instead used BMI. 16 …”

Section: Introductionmentioning

confidence: 99%

Infant fat mass and later child and adolescent health outcomes: a systematic review

Amati,

McCann,

Castañeda-Gutiérrez

et al. 2023

Arch Dis Child

Self Cite

View full text Add to dashboard Cite

show abstract

The Prevalence of Childhood Obesity Depends on Which Body Composition and Anthropometric Measurement and Cutoff Were Used

Xu,

Zhu,

Qin

et al. 2024

Measurement in Physical Education and Exercise Science

View full text Add to dashboard Cite

Serum biomarkers in the metabolic dysfunction-associated steatotic liver fibrosis diagnosis in children

Stepanov,

Zavhorodnia,

Klenina

et al. 2024

GASTRO

View full text Add to dashboard Cite

Background. The COVID-19 epidemic and the war in Ukraine have led to a significant increase in the number of children suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of individuals at risk of rapid disease progression and development of irreversible liver changes. The search for alternative noninvasive markers suitable for the early detection of liver fibrosis in children remains extremely relevant. The aim of the study was to determine the diagnostic value of serum fibrosis markers and their relationship with sonographic and body composition parameters in children with MASLD. Materials and methods. The case-control study included 80 children aged 6 to 17 years (mean of (12.15 ± 2.51) years). The presence of steatosis and liver fibrosis was determined by transient elastography (FibroScan® 502 touch F60156, Echosens, France). All subjects underwent anthropometric studies to determine body mass index. If it was within one-two Z-score, overweight was diagnosed. If the body mass index exceeded two Z-score, obesity was diagnosed. According to transient elastography and body mass index, all children were divided into four groups: group I — 27 children with MASLD and fibrosis ≥ F1, group II — 35 children with MASLD without fibrosis, group III — 18 obese or overweight children without MASLD and without fibrosis. The control group IV consisted of 14 children with normal weight without MASLD and without fibrosis. The groups had no significant differences in age and gender distribution. The study of body composition was performed by bioimpedance analysis using a TANITA MC-780MA analyzer (manufactured by Maeno-cho, Itabashi-ku, Tokyo, Japan). Quantitative determination of the serum concentration of vascular endothelial growth factor (VEGF) was performed by enzyme-linked immunosorbent assay (ELISA) using test systems from Wuhan Fine Biotech Co., Ltd (China) according to the manufacturer’s recommendations. The level of serum cytokeratin 18 (CK-18) was evaluated with IDL Biotech AB kits (Sweden) for ELISA. Serum content of transforming growth factor beta 1 (TGF-β1) was studied using an ELISA test system from IBL International (Germany). Fibrogenesis processes were evaluated by the serum content of free hydroxyproline (HPf), protein-bound hydroxyproline (HPp/b) and glycosaminoglycans (GAG). Results. The study revealed a significant increase in the level of CK-18 and TGF-β1 in children with MASLD-associated liver fibrosis. In children with liver fibrosis, an increase in the ratio of HPf/HPp/b and the level of GAG in the blood serum was observed compared to patients with MASLD without fibrosis and with overweight and obese children. The threshold value of CK-18 for liver fibrosis diagnosis was 90.3 U/l (sensitivity 81.3 %, specificity 76.9 %, AUC 0.843, p < 0.001). The sensitivity of the threshold value of serum TGF-β1 (96.8 pg/mL) in children with MASLD was 80.0 %, specificity 65.7 %, AUC 0.787 (p < 0.001). Threshold value of serum GAG (4.24 mmol/L) demonstrated a sensitivity of 70.6 % and a specificity of 69.6 %, AUC 0.743 (p < 0.01). CK-18, TGF-β1, GAG shown a positive correlation with liver stiffness and elasticity, body composition of MASLD children and had high levels of diagnostic accuracy, which allows them to be used in children when screening for MASLD-associated liver fibrosis. Conclusions. Children with liver fibrosis are characterized by elevated serum levels of CK-18, VEGF, TGF-β1, HPp/b and GAG. The threshold values of CK-18 (more than 90.3 U/l), TGF-β1 (above 96.8 pg/mL) and GAG (more than 4.24 mmol/l) have high sensitivity and specificity, which allows them to be used for the diagnosis of liver fibrosis in children with MASLD.

show abstract

Measuring body composition in children: research and practice

Cited by 4 publications

References 35 publications

Infant fat mass and later child and adolescent health outcomes: a systematic review

Infant fat mass and later child and adolescent health outcomes: a systematic review

The Prevalence of Childhood Obesity Depends on Which Body Composition and Anthropometric Measurement and Cutoff Were Used

Serum biomarkers in the metabolic dysfunction-associated steatotic liver fibrosis diagnosis in children

Contact Info

Product

Resources

About